Answers are grounded in this paper and cite their sources.
Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.
No takes yet. Share an insight, caveat, or question.
Hatz et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: